THRIVE Trademark

Trademark Overview

On Friday, May 31, 2024, a trademark application was filed for THRIVE with the United States Patent and Trademark Office. The USPTO has given the THRIVE trademark a serial number of 98579402. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, May 31, 2024. This trademark is owned by Affini-T Therapeutics, Inc.. The THRIVE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of genetically modified cells, namely the production of fit and proliferative T-cells exhibiting naive and stem cell memory phenotypes, through gene editing and cell therapy manufacturing
thrive

General Information

Serial Number98579402
Word MarkTHRIVE
Filing DateFriday, May 31, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, May 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesResearch and development in the field of genetically modified cells, namely the production of fit and proliferative T-cells exhibiting naive and stem cell memory phenotypes, through gene editing and cell therapy manufacturing

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 31, 2024
Primary Code042
First Use Anywhere DateTuesday, June 27, 2023
First Use In Commerce DateTuesday, June 27, 2023

Trademark Owner History

Party NameAffini-T Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Friday, May 31, 2024NEW APPLICATION ENTERED

Related Keywords

thrive cells cell through memory phenotypes gene manufacturing therapy editing stem